- Home
- BTAI vs GNS Comparison
BTAI vs GNS Comparison
Compare BTAI & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTAI | GNS |
|---|---|---|
| Founded | 2017 | 2002 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7M | 43.9M |
| IPO Year | 2018 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BTAI | GNS |
|---|---|---|
| Price | $1.62 | $0.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $26.67 | N/A |
| AVG Volume (30 Days) | 494.6K | ★ 852.8K |
| Earning Date | 03-26-2026 | 09-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $752,000.00 | ★ $5,749,894.00 |
| Revenue This Year | N/A | $82.78 |
| Revenue Next Year | $265.60 | $85.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.17 | $0.21 |
| 52 Week High | $8.08 | $1.92 |
Technical Indicators
Market Signals| Indicator | BTAI | GNS |
|---|---|---|
| Relative Strength Index (RSI) | 44.02 | 29.93 |
| Support Level | $1.36 | $0.40 |
| Resistance Level | $1.72 | $0.50 |
| Average True Range (ATR) | 0.12 | 0.04 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 45.10 | 4.61 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.